Skip to main content
Journal cover image

Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry.

Publication ,  Journal Article
Liu, L; Yu, X; Li, Z; He, X; Zha, J; Lin, Z; Hong, Y; Zheng, H; Lai, Q; Ding, K; Jia, X; Fu, G; Yu, H; Yang, H; Li, Z; Young, KH; Xu, B
Published in: J Hematol Oncol
August 22, 2022

BACKGROUND: Patients with follicular lymphoma (FL) who experience disease progression within 24 months (POD24) have inferior outcomes. The tumor immune microenvironment (TIME) plays a crucial role in pathogenesis and progression of follicular lymphoma (FL). However, TIME evolution during progression of disease within 24 months (POD24) is elusive. METHODS: Spatially resolved and single-cell image mass cytometry with a panel of 36 metal-tagged antibodies was used to quantitatively analyze the TIME structure in 13 paired FLs at diagnosis and POD24. RESULTS: Follicles and peri-follicular regions were well dissected in structure. Peri-follicular regions represented a barrier for immune infiltration into the follicles. More FL-cells in the peri-follicular regions suffered CD8+T cells attacks under simultaneous protection of regulatory T cells (Tregs) and/or macrophages compared with that in the follicles irrespective of POD24. During POD24, increased CD163- macrophages with PD-1 ligand upregulation and decreased CD8+T cells with upregulated LAG-3 expression around FL-cells were observed in the follicles. Spatial analyses demonstrated that FL-cells interacted more intimately with macrophages than with Tregs and less with cytotoxic T cells in both peri-follicular regions and follicles during POD24. In comparison, macrophages also cooperated more frequently with Tregs to simultaneously hijack FL-cells, creating an enhanced immunosuppressive environment in both peri-follicular and follicular regions during POD24. CONCLUSIONS: Peri-follicular regions function as a barrier by recruiting both CD8+T cells and immunosuppressive cells, protecting follicular FL-cells from immune attack at diagnosis or POD24. FL-cells reside in a more immune-compromised microenvironment and evade immune cell attacks during POD24. Novel immunotherapeutic approaches harnessing LAG-3, macrophages, and Tregs will be empowered to overcome poor outcomes in patients with FL POD24.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Hematol Oncol

DOI

EISSN

1756-8722

Publication Date

August 22, 2022

Volume

15

Issue

1

Start / End Page

115

Location

England

Related Subject Headings

  • Tumor Microenvironment
  • Lymphoma, Follicular
  • Immunosuppressive Agents
  • Image Cytometry
  • Humans
  • Disease Progression
  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Liu, L., Yu, X., Li, Z., He, X., Zha, J., Lin, Z., … Xu, B. (2022). Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry. J Hematol Oncol, 15(1), 115. https://doi.org/10.1186/s13045-022-01326-z
Liu, Long, Xingxing Yu, Zhifeng Li, Xiaohua He, Jie Zha, Zhijuan Lin, Yan Hong, et al. “Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry.J Hematol Oncol 15, no. 1 (August 22, 2022): 115. https://doi.org/10.1186/s13045-022-01326-z.
Liu, Long, et al. “Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry.J Hematol Oncol, vol. 15, no. 1, Aug. 2022, p. 115. Pubmed, doi:10.1186/s13045-022-01326-z.
Liu L, Yu X, Li Z, He X, Zha J, Lin Z, Hong Y, Zheng H, Lai Q, Ding K, Jia X, Fu G, Yu H, Yang H, Young KH, Xu B. Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry. J Hematol Oncol. 2022 Aug 22;15(1):115.
Journal cover image

Published In

J Hematol Oncol

DOI

EISSN

1756-8722

Publication Date

August 22, 2022

Volume

15

Issue

1

Start / End Page

115

Location

England

Related Subject Headings

  • Tumor Microenvironment
  • Lymphoma, Follicular
  • Immunosuppressive Agents
  • Image Cytometry
  • Humans
  • Disease Progression
  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1102 Cardiorespiratory Medicine and Haematology